Neuro-Developmental
follow up of high-risk newborns using hammersmith-dubowitz method
Lakshmi Priya C.1, Sravanthi N. L.2,
Vijayalakshmi B.3, Kantakumari P.4
1Dr. Lakshmi Priya Chadalawada, Post Graduate, 2Dr. Nalluru
Lakshmi Sravanthi, Associate Professor, 3Dr.Vijayalakshmi Bhimireddy,
Professor, 4Dr. Kantakumari Pinnamaneni, Associate Professor; all
authors are affiliated with NRI Medical College, Andhra Pradesh, India.
Corresponding Author: Dr. Nalluru Lakshmi Sravanthi, Associate
Professor, NRI Medical College, Mangalagiri
Road, Chinakakani, Guntur, Andhra Pradesh. Email-glsravanthi@gmail.com
Abstract
Background and Objectives: High risk infants are prone to delay in
neurological development due to perinatal damage sustained by the brain and
nervous tissue. Despite being on regular
follow-up, delayed neurological development is often missed even by experienced
examiners as most of the examination and history are subjective. We aim to validate an objective scoring
system- the Hammersmith-Dubowitz neurological exam which was extensively
researched and developed taking into consideration normal responses from a
normal cohort. Materials and Methods: Over
a period of two years, 112 infants were categorized as high-risk newborns and
were followed up for a period of one year of age.The children underwent
detailed milestone assessment, physical and neurological examination by two
independent examiners along with objective scoring with Hammersmith infant
neurological exam. Any abnormality in these tests was considered delayed
development. Results: Of the 112
infants, 102 came for at least one follow up and 81 completed one year follow
up with a mean follow up duration of 9.42 months. On the combined assessment
scale of developmental, physical and complete neurological examination 7.84%
infants were found to be abnormal. However, on objective assessment with
Hammersmith neurological examination 16.67 % of the infants were found to have
abnormal neurological development. Conclusion:
Hammersmith neurological examination is a useful objective scoring tool to
identify delayed neurological development early.
Key words: Hammersmith neurological exam, High risk
infant, Objective neurological assessment
Author Corrected: 20th June 2019 Accepted for Publication: 24th June 2019
Introduction
The two important aspects of neonatal care are the fragility of a
neonate and the consequences which can result from management of such a patient
which greatly impacts his/her future. A second’s delay might lead to years of
morbidity and dependence especially when the damage is Neurological. High-risk
newborns (HRNB) are especially vulnerable to neurological damage and its complications
[1,2]. Early identification of these children can help in better management of
their disability [3,4].
The neurological assessment of newborns has evolved through several
stages to reach a modern era. The current standard of examination is using one
of the many scoring scales to objectively assess the neurological status and
express it in numbers or other forms so that a uniform scale exists for their
measurement and comparison irrespective of the examining person. The prominent
of these scales include Infant Motor Profile (IMP), Harrison Infant Neuromotor
Test (HINT), Alberta Infant Motor Scale (AIMS), Hammersmith Infant Neurological
Examination (HINE), Bayley Scales of Infant Development II (BSID), Amiel-Tison
neurological assessment, Peabody Developmental Motor Scales (PDMS), The
neonatal behavioral assessment scale (NBAS); Neurobehavioral assessment of the
preterm infants (NAPI); the Assessment of preterm infant’s behaviour (APIB);
the Neonatal intensive care unit network neurobehavioral scale (NNNS); and
Dubowitz scale. Of these HINE is proved
in multiple studies to be more comprehensive and superior in identifying
delayed neurological development and milestone progress [5,6].
The use of scales like HINE has enabled early identification of infants
with delayed neurological development and early behavioral changes. These
scales are specifically designed as screening tests to identify children at
risk for these conditions. These include various components like motor,
sensory, behavioral and milestones. Most of these scales requires prior
training and experience whether by formal or informal means for their use. The
main criticism against these scales are the fact that administration of such an
objective examination is time-consuming, requires expertise and children may
not be available for follow-up. Moreover, these scales are effective only when
done serially and well documented. The clinical effectiveness of these scales
considering the above said factors in a clinical environment that exists in
India is not proven to date. Thus the questions arise - Are these scales
effective in our clinical setting? Will the follow-up compliance be good in our
country, where there is high prevalence of poverty and illiteracy? Will these
scales reduce the need for unnecessary investigations in the infant population
at risk?
Since the purpose of infant follow-up in first year of age is to
identify impairments as early and broadly as possible and to provide guidance
for families. Their choice of standardized assessment is heavily influenced by
feasibility and prognostic considerations. In particular, examinations need to
balance the demands of clinical imperatives and time constraints. We selected
the HINE for implementation in this study because it is a well-studied
neurological examination in healthy or high-risk infants and is an objective
scale and results are expressed in numbers easily understandable and without
controversy.
The HINE is an easily performed and relatively brief standardized and
scorable clinical neurological examination for infants aged between 2 and 24
months, accessible to all clinicians, with good inter-observer reliability even
in less experienced staff. It has no associated costs such as lengthy
certifications or proprietary forms. The use of the HINE optimality score and
cutoff scores provides prognostic information on the severity of motor outcome.
The HINE can further help to identify those infants needing specific
rehabilitation programs. It includes 26 items assessing cranial nerve function,
posture, quality, and quantity of movements, muscle tone, and reflexes and
reactions. Each item is scored individually (0, 1, 2, or 3), with a sum score
of all individual items (range 0 to 78). A questionnaire with instructions and
diagrams is included on the scoring sheet, similar to the Dubowitz neonatal
neurological examination. Optimality scores for infants three to 18 months are
based on the frequency distribution of neurological findings in a typical
infant population: when an item is found in at least 90% of infants, it is
considered optimal [7].
Sequential use of the HINE allows the identification of early signs of
cerebral palsy and other neuromotor disorders, whereas individual items are
predictive of motor outcomes. For example, in preterm infants assessed between six-
and 15-months corrected age, scores greater than 64 predict independent walking
with a sensitivity of 98% and specificity of 85% [8]. Conversely, scores less
than 52 were highly predictive of cerebral palsy and severe motor impairments [9].
Materials and Methods
Place of Study: NRI medical college and hospital,
Chinakakani.
Study Design: Prospective observational study.
Period of Study: October 2016 to September 2018.
Study Population: The present study was a single-centre,
prospective observational study. It studies the ability of Hammersmith infant
neurological examination (HINE) scoring system in identifying infants with
developmental delay among the high-risk TERM newborns delivered at NRI Medical
College and Hospital from October 2016 to September 2018. As a part of the
study, all the TERM infants delivered at our hospital were considered for
eligibility. As all the infants were delivered at the same institute and all
were term only those satisfying criteria for high-risk newborns were included.
Infants born out of both normal vaginal delivery and caesarean section were
included in the study. The inclusion criteria were as follows:
Selection Criteria, Inclusion Criteria:All high-risk term newborns were included in
the study with the criteria for high risk being - 1. Major morbidities such as
chronic lung disease, intraventricular haemorrhage, and periventricular
leucomalacia 2. Perinatal asphyxia - Apgar score 3 or less at 5 min and/or
hypoxic-ischemic encephalopathy 3. Surgical conditions like Diaphragmatic
hernia, Tracheo-oesophageal fistula 4. Small for date (97th centile) 5.
Mechanical ventilation for more than 24 hours 6. Persistent prolonged
hypoglycemia and hypocalcemia 7. Seizures 8. Meningitis.9. Shock requiring
inotropic/vasopressor support 10. Infants born to HIV-positive mothers 11. Twin
to twin transfusion 12. Neonatal bilirubin encephalopathy 13. Major
malformations 14. Inborn errors of metabolism / other genetic disorders 15.
Abnormal neurological examination at discharge
Exclusion Criteria: Those who refused consent or refused to come
for follow-up due to geographical or personal reasons. 2. Mortality during the
period of study 3. Patients who withdrew treatment and were discharged against
medical advice were excluded.
Procedures and Methods of Data Collection: After the newborn is delivered, he/ she are
assessed for eligibility to be recruited. If the infant falls under the
high-risk category the infant is assessed with HINE neonatal assessment at
discharge. Any neurological damage identified is immediately referred to the
specialist clinic.
Once the child is recruited, basic data and maternal data were noted
including all possible risk factors. After discharge, the children were
followed up over the phone and were called for repeat follow up examinations at
3, 6, 9 and 12 months [10], coinciding with their vaccination schedule. The
children were administered the HINE infant scoring system and the scores were
documented. Any infants with low scores were referred to a specialist clinic
and these children were in close follow up along with regular examinations.
Those children identified with the low score were followed up to note any
improvement in the score with intervention. A score of < 60 as a sign of
retardation and referred for further management and investigations.
The infants with normal scores were followed up to one year or further
for any neurological deficits or significant delay in milestones. All these
infants were followed up for a period of one year with interval assessments at
3, 6, 9 and 12 months of age coinciding with their vaccination schedule. The
children underwent detailed milestone assessment, physical and neurological
examination by two independent examiners with a minimum two years of experience
in newborn assessment along with objective scoring with Hammersmith infant
neurological exam. Any abnormality in these tests was considered delayed
development. The follow-up ended after one year from birth. All the data was
compiled and statistically analysed.
Statistical Methods: Descriptive and inferential statistical
analysis has been carried out in the present study. Significance is assessed at
5% level of significance. The following assumptions on data are made.
Assumptions: 1. Dependent variables should be normally distributed, 2.Samples
drawn from the population should be random, Cases of the samples should be
independent. Chi-square/ Fisher Exact
test has been used to find the significance of study parameters on categorical
scale between two or more groups.
Ethical Considerations:1. Approval to carry out the study was sought
from the Department of Pediatrics, NRI Medical College and Ethics Committee,
NRI Medical College, Chinnakakani. 2. The nature and benefits of the study were
explained to the parents of the infants in a language they understood. 3.
Consent was obtained by signature or thumbprint on the consent form
Results
Number of Subjects: 112 A total of 2173 potential newborns were
screened for recruitment. Of which 112 were high-risk term newborns. All the
infants were admitted to NICU with different diagnoses and were treated
appropriately. Eight of the infant’s parents were not willing to come for
further follow-up or be a part of the study. 22 infants were discharged against
medical advice and 19 infants died during treatment due to various causes. Of
the 112 infants discharged from the NICU, all were assessed and were called for
a repeat assessment at 3, 6, 9, and 12 months coinciding with their vaccination
schedule. Of the 112 infants, only 102 presented for one follow up at least.
The infants were stratified based on normal and abnormal HINE. Under both the
groups, some infants lost to follow-up. And the infants with abnormal HINE
scores underwent necessary interventions after which some of them showed
improved HINE scores on further follow-ups.
Table-1: Normal and abnormal HINE groups follow-up
Normal group on follow up |
3months |
6months |
9months |
12months |
Normal group lost to follow up |
85 |
79 |
74 |
68 |
Abnormal group lost to follow
up |
|
6 |
5 |
6 |
Abnormal group lost to follow
up |
17 |
14 |
10 |
7 |
Abnormal group improved to
normal |
|
1 |
1 |
2 |
|
|
2 |
3 |
1 |
A total of 112 newborns were selected as
high-risk term newborns fulfilling the inclusion criteria who were assessed at
the time of discharge and advised to come for follow up. At 3 months of age,
102 infants came for follow-up of which 85 had normal HINE scores and 17 had
abnormal HINE scores whereas 10 infants lost to follow up. At 6 months of age,
95 infants came for follow-up of which 79 had normal HINE scores, 14 had
abnormal HINE scores, 2 infants from the abnormal group improved to normal HINE
scores making a total of 81 infants with normal scores whereas 7 infants lost
to follow-up. At 9 months of age, 89 infants came for follow-up of which 74 had
normal HINE scores, 10 had abnormal HINE scores, 3 infants from abnormal group
improved to normal HINE scores making a total of 79 infants with normal scores
whereas 6 infants lost to follow-up. At 12 months of age, 81 infants came for follow-up
of which 68 had normal HINE scores, 7 had abnormal HINE scores, 1 infant from
abnormal group improved to normal HINE score making a total of 74 infants with
normal scores whereas 8 lost to follow-up.
Out of the 112 high-risk term newborns included in the study, 50.9% (57
out of 112) were female babies and 49.1% (55 out of 112) were male. 51 of
infants completed 38 weeks of gestation, 16 completed 39 weeks and 8 completed
40 weeks of gestation. 55 infants were born through lower segment caeserian
section and 57 infants through normal vaginal delivery. 21 of the infants
weighed less than 2.5kg and 91 of them weighed equal to or greater than 2.5kg.
Of the 112 high risk term newborns, 96(85.7%) were not ventilated
whereas 16 (14.3%) of them were ventilated using a mechanical ventilator.
Out of the 112 high-risk term newborns include in the study , at 3
months follow up - a total of 91.1% (102 out of 112) babies came for follow-up of which 75.9% (85
out of 102) had normal HINE scores and 15.2% (17 out of 102) had abnormal HINE
scores and 8.9% (10 out of 112) lost to follow-up.
Table-2: Determinants of HINE at 3 months
follow up
variable |
Category |
HINE at 3 months |
P value |
|||
Abnormal (<60) |
Normal(GE 60) |
|||||
count |
% |
count |
% |
|||
Sex |
Female |
8 |
16 |
42 |
84 |
1 |
Male |
9 |
17.3 |
43 |
82.7 |
||
GA |
37 |
9 |
20.5 |
35 |
79.5 |
0.12 |
38 |
3 |
8.6 |
32 |
91.4 |
||
39 |
2 |
12.5 |
14 |
87.5 |
||
40 |
3 |
42.9 |
4 |
57.1 |
||
Mode
of delivery |
LSCS |
7 |
14 |
43 |
86 |
0.6 |
NVD |
10 |
19 |
42 |
80.8 |
||
Birth
weight |
<2.5 |
3 |
15 |
17 |
85 |
1 |
GE
2.5 |
14 |
17.1 |
68 |
82.9 |
||
ventilation |
No |
13 |
14.8 |
75 |
85.2 |
0.24 |
Yes |
4 |
28.6 |
10 |
71.4 |
Out of the 112 high-risk term newborns
include in the study , at 6 months follow up - a total of 84.8% (95 out of
112) babies came for follow-up of which
72.3% (81 out of 95) had normal HINE scores and 12.5% (14 out of 95) had
abnormal HINE scores and 15.1% (17 out of 112) lost to follow-up.
Table-3:Determinants of HINE at 6 months
follow up:
variable |
category |
HINE at 6 months |
P value |
|||
Abnormal |
Normal |
|||||
count |
% |
count |
% |
|||
Sex |
Female |
6 |
13.3 |
39 |
86.7 |
0.78 |
Male |
8 |
16 |
42 |
84 |
||
GA |
37 |
8 |
20.5 |
31 |
79.5 |
0.28 |
38 |
3 |
9.1 |
30 |
90.9 |
||
39 |
1 |
6.3 |
15 |
93.8 |
||
40 |
2 |
28.6 |
5 |
71.4 |
||
Mode
of delivery |
LSCS |
5 |
10.9 |
41 |
89.1 |
0.39 |
NVD |
9 |
18.4 |
40 |
81.6 |
||
Birth
weight |
<2.5 |
2 |
11.1 |
16 |
88.9 |
1 |
GE2.5 |
12 |
15.6 |
65 |
84.4 |
||
ventilation |
NO |
11 |
13.4 |
71 |
86.6 |
0.4 |
YES |
3 |
23.1 |
10 |
76.9 |
Out of the 112 high-risk term newborns
include in the study, at 6 months follow up - a total of 84.8% (95 out of
112) babies came for follow up of which
72.3% (81 out of 95) had normal HINE scores and 12.5% (14 out of 95) had
abnormal HINE scores and 15.1% (17 out of 112) lost to followup.
Table-4: Determinants of HINE at 9months
Variable |
Category |
HINE at 9 months |
P value |
|||
Abnormal |
Normal |
|||||
count |
% |
Count |
% |
|||
Sex |
Female |
5 |
11.9 |
37 |
88.1 |
1 |
Male |
5 |
10.6 |
42 |
89.4 |
||
GA |
37 |
6 |
16.2 |
31 |
83.8 |
0.35 |
38 |
3 |
9.4 |
29 |
90.6 |
||
39 |
0 |
0 |
15 |
100 |
||
40 |
1 |
20.0 |
4 |
80 |
||
Mode
of delivery |
LSCS |
3 |
7 |
40 |
93 |
0.32 |
NVD |
7 |
15.2 |
39 |
84.8 |
||
Birth
weight |
<2.5Kg |
1 |
6.3 |
15 |
93.8 |
0.68 |
2.5 |
9 |
12.3 |
64 |
87.7 |
||
ventilation |
No |
7 |
9.2 |
69 |
90.8 |
0.16 |
Yes |
3 |
23.1 |
10 |
76.9 |
At 9 months followup, a total of 79.46% (89
of 112) babies came for follow up, of which 11.23% (10 of 89) babies had abnormal HINE scores and 88.76%(79
of 89) babies had normal HINE scores and20.53%(23 of 89) babies were lost to
follow up.
Table-5: Showing HINE at 12 months follow up
Variables |
Category |
HINE at 12 months |
P value |
|||
Abnormal |
Normal |
|||||
Count |
% |
count |
% |
|||
Sex |
Female |
4 |
10.3 |
35 |
89.7 |
0.71 |
Male |
3 |
7.1 |
39 |
92.9 |
||
GA |
37 |
5 |
13.9 |
31 |
86.1 |
0.24 |
38 |
1 |
4.0 |
24 |
96 |
||
39 |
0 |
|
15 |
100 |
||
40 |
1 |
20.0 |
4 |
80 |
||
Mode
of delivery |
LSCS |
3 |
7.5 |
37 |
92.5 |
1 |
NVD |
4 |
9.8 |
37 |
90.2 |
||
Birth
weight |
<2.5 |
1 |
6.7 |
14 |
93.3 |
1 |
2.5 |
6 |
9.1 |
60 |
90.9 |
||
Ventilation |
Yes |
6 |
8.6 |
64 |
91.4 |
1 |
No |
1 |
9.1 |
10 |
90.9 |
Out of the 112 high-risk term newborns
include in the study, at 12 months follow up - a total of 72.3% (81 out of
112) babies came for followup of which
66.1% (74 out of 81) had normal HINE scores and 6.3% (7 out of 81) had abnormal
HINE scores and 27.7% (31 out of 112) lost to followup.
Table-6:Improvement in abnormal HINE scores
Improved |
frequency |
Percentage |
No |
11 |
65 |
Yes |
6 |
35 |
Total |
17 |
100 |
Initially at the beginning of the study, it
took around 15 to 20 minutes for the assessment of HINE score each time in a
well cooperative infant. Gradually with repetitive assessments and experience,
the time taken to examine decreased to a maximum of 5 minutes in a well
cooperative infant. Just like Ballards scoring which initially took time for
assessment but eventually with practice, it is routinely done easily, similarly
HINE can also be performed easily over time. This makes it easier for use in
regular clinical practice.
Discussion
Delayed neurological development is the leading cause of permanent
disability in a newborn infant. Not only does it affect the infant alone, but
also causes a major social and economic burden on the family who will have to
manage a morbidly disabled child. In a developing country like India, the
social effects of such a disabled child are multiplied manifold due to the
scarce resources available for treatment and the poor financial means available
with the family. Ultimately these children due to lack of adequate care have
high mortality rates within five years of life [10] Thus, identifying these
children early is of prime importance. On looking up the various means for the
assessment of these high-risk infants, we found the Hammersmith Infant
Neurological Examination (HINE). Though the HINE score has previously been
evaluated in various settings, a complete prospective trail using it has never
been done on the Indian population. Moreover, we used the scale exclusively in
high-risk term infants as a screening tool in a specified population set to
identify early developmental delay which is unique to our study. We have
compared our study with various other studies and compared the results.
Demography and maternal factors: The gender distribution among the infants in
our study is 49.1% male and 50.9% females which were not on expected lines with
respect to the Indian population. However, this can be explained by the lack of
prenatal sex determination of these babies. The findings correlated with those
of Zafar et al. performed in Indian population though in a different region.
However, among the 31 infants lost to follow up 24(77.4%) were female infants
which reflects the lack of importance given to the health of the female child
among the low socioeconomic and low-income groups in Indian population. These
findings are unique to our study.
Multiple maternal factors have
been implicated in the neurological growth retardation in various studies in
the west [1,5]. However when the factor of prematurity has been eliminated and
the results analyzed no prenatal or maternal factors including mode of delivery
affected the normal development of the nervous system of a newborn. The
commonest gestational age was 37 and 38 weeks as seen in many Indian studies
[10,11].
The mode of delivery is almost equal with 49.1% of children born out of
LSCS and the rest were by NVD. Though these rates are significantly higher than
the rest of the Indian population which is 17.2% [12,13], this can be explained
by the fact that the study population consists of high-risk infants who in turn
would have been high-risk deliveries or had fetal distress in the prenatal
period.
The birth weight in our study was on lines with the rest of the Indian
population. 16% of these high-risk newborns were ventilated. Considering the
fact that those infants who expired during the course of the study were
excluded this number might have been higher.
Fetal Outcomes: Perinatal asphyxia, neonatal seizures, RDS
and Neonatal jaundice are the most common condition among infants classified as
high-risk newborns. This correlates well with the data published by Simeonsson
et al [14]. Overall in the study population with the use of the HINE score we
were able to detect 15.1% of the infants had a significant delay in
neurological development. Though the number varies significantly in various
studies ranging from 6.3% to 33%, [15,16] the relatively lower number in our 89
study though the study population is of high-risk infants can be explained by
the following factors: a. This is not a population based study, it is among the
infants treated at a tertiary care centre with a good NICU setup and
availability of neonatologist throughout. b. The high rate of LSCS (49.1%)
reflects the standard of care received by these infants and their mothers in
the perinatal period. c. The careful follow-up and detection of these
conditions. d. The follow-up period is only upto one year which is a limitation
as conditions like autism are not usually evident by one year of age. However
since the main aim of the study was not to calculate the prevalence of the
condition these findings need not be attributed major significance. 27.7% of
the infants were lost to follow-up at the end of one year with most of them
being female infants; The follow-up rate was good compared to other studies in
this arena [5,6]. This can be attributed to clubbing the infant examination
schedule with that of the vaccination schedule. Since the vaccination compliance
in India is upto 85% in semi-urban and urban areas [12] we sought to replicate
these numbers and partially succeeded. With combining of the vaccination
schedule and infant examination at 3rd months, 6th month, 9th month and one
year we were able to achieve high follow up rates and hence recommend the same
to be replicated in future studies to maintain high follow up rates at least
upto one year of age. Moreover prior education of the patients about the need
for regular follow up, maintaining a database of contact details including the
telephone numbers and months contact over telephone also resulted in better
followup and sustenance rates.
Hammersmith Infant
Neurological Examination: With the use of HINE score, we were able to identify 17(15.1%) infants
with abnormal neurological development as early as at 3rd month of age. Of
these infants, 6 of the 17(35.5%) improved back to normal HINE score by one
year with appropriate referral and early initiation of treatment. Thus HINE
score helped identify these infants early and improved outcomes with early
identification. The sensitivity of Hammersmith Score was 90.9% in our study
with a specificity of Hammersmith Score nearly 100%. The positive predictive
value was 100%. Mean duration of detection of developmental delay using the
hammersmith score was 5.1 months. Only one patient was detected with delay in
milestones with a normal neurological examination.
The objective scoring system of the HINE
assessment gives a clear-cut picture of the neurological development status of
the infant and is very useful to identify these children early. Similar
findings were noted in two studies by Romeo et al. [17,18] using HINE
assessment. Of the various assessments evaluated by multiple authors, [19, 20,21,22]
the HINE assessment is definitely better in many aspects as it is holistic,
comprehensive, short, uncomplicated and requires minimum training.
Use of HINE score in routine OPD follow- up of high-risk newborns is rewarding and helps in early
identification of infants requiring special treatment and other assistance.
This has been proved in our study that by serial follow-up of these infants we
can improve the overall outcomes with timely intervention and referral.
With regular use of HINE score in our daily
clinical practice we were able to definitely state that though in the initial
days of use it was time consuming and was not easy to master as time passed we
were able to perform the follow up examination of each infant within 5 minutes
duration thus obtaining vital information for the management of the infant. As
the HINE score can be done serially, it can also be used to assess the response
to intervention as it was successfully demonstrated by us with an improvement
of 6 of 17 children with timely intervention. There are no extra costs involved
as the HINE assessment is available free of cost, needs no extra training and
is noninvasive. As children also do not experience any pain or discomfort the
compliance by parents is also high.
Though the use of HINE is highly rewarding in
the follow-up of a high-risk newborn, it is time-consuming and can become a
hurdle to daily work if performed on every infant. Since the incidence of
delayed neurological development in normal infants is quite less, its use as a
screening tool in regular population is limited. It is best used as a screening
tool in the high-risk population and as a follow-up tool to monitor progress of
borderline cases and to assess improvement or deterioration in children with
proven developmental delay. More studies need to be done with use of the HINE
scale among high-risk infants to further gauge the efficiency of this scale at
identifying and improving outcomes in infants with delayed neurological
development. More widespread training should be available to all pediatricians
to easily and quickly perform this examination without confusion, and hence be
able to identify infants at risk of delayed development.
Conclusion
Hammersmith Infant Neurological examination
(HINE) can be used to objectively assess and follow-up neuro-developmental
outcomes in high-risk newborns • Hammersmith Infant Neurological examination
can be used serially in infants upto one year of age. • Identification of
infants with delayed development and correlate factors causing the same. • HINE
can be used as a neurological screener tool in Clinical practice • HINE
objective score can be done in a regular clinical setting in OPD within 5
minutes with practice and has good inter-observer reliability • HINE offers
early detection of neuro-developmental delay through follow-ups at regular
intervals • HINE objective score with early interventions provides better
outcomes
What this study adds
1. HINE can be used as a neurological
screening tool in clinical practice in Indian setting.
2. HINE scores allows for quantitative
evaluation of neurological findings and developmental trajectories
3. It increases the diagnostic precision but
does not increase the overdiagnosis.
References